DETRUSITOL 1 MG FILM-COATED TABLETS
Active substance(s): TOLTERODINE L-TARTRATE
PGM ASCOLI PICENO PLANT
IS DETRUSITOL CPR UK
Country - Language:
STIST0206 (124,00 x 600,00) - Prepiegata stesa 124,00 x 300,00 - N. lembi piega 2 - DATA MATRIX
COPYRIGHT / PROPRIETA'
Pfizer Italia S.r.l.
DO NOT TAMPER - RETURN AFTER PRINTING / VIETATA LA MANOMISSIONE - RENDERE DOPO LA STAMPA
PACKAGE LEAFLET: INFORMATION FOR THE USER
1 mg & 2 mg
Read all of this leaflet carefully before you start using this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist
• This medicine has been prescribed for you. Do not pass it on to others. It may
harm them, even if their symptoms are the same as yours.
• If any of the side effects get serious, or if you notice any side effects not listed
in this leaflet, please tell your doctor or pharmacist.
Painful or difficult urination, inability to empty the bladder
Tiredness, chest pain, extra fluid in the body causing swelling (e.g. in the ankles)
Uncommon side effects (occurs in less than 1 in 100 patients) are:
• Allergic reactions
• Increased heart rate, heart failure, irregular heartbeat
• Heart burn
• Memory impairment
Additional reactions reported include severe allergic reactions, confusion, hallucinations,
flushed skin angioedema, and disorientation. There have also been reports of
worsening symptoms of dementia in patients being treated for dementia.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible
side effects not listed in this leaflet. You can also report side effects directly (see
details below). By reporting side effects you can help provide more information on
the safety of this medicine.
In this leaflet:
1. What Detrusitol is and what it is used for
2. Before you take Detrusitol
3. How to take Detrusitol
4. Possible side effects
5. How to store Detrusitol
6. Further information
Yellow Card Scheme website: www.mhra.gov.uk/yellowcard
1. What DETRUSITOL is and what it is used for
The active substance in Detrusitol is tolterodine. Tolterodine belongs to a class of
medicinal products called antimuscarinics.
Detrusitol is used for the treatment of the symptoms of overactive bladder syndrome.
If you have overactive bladder syndrome, you may find that:
• you are unable to control urination,
• you need to rush to the toilet with no advance warning and/or go to the toilet
2. Before you take DETRUSITOL
No special precautions for storage.
Do not take Detrusitol if you:
• are allergic (hypersensitive) to tolterodine or any of the other ingredients in
• are unable to pass urine from the bladder (urinary retention)
• have an uncontrolled narrow-angle glaucoma (high pressure in the eyes with loss
of eyesight that is not being adequately treated)
• suffer from myasthenia gravis (excessive weakness of the muscles)
• suffer from severe ulcerative colitis (ulceration and inflammation of the colon)
• suffer from a toxic megacolon (acute dilatation of the colon).
Medicines should not be disposed of via wastewater or household waste. Ask your
pharmacist how to dispose of medicines no longer required. These measures will
help to protect the environment.
Take special care with DETRUSITOL
• If you have difficulties in passing urine and/or a poor stream of urine
• If you have a gastro-intestinal disease that affects the passage and/or digestion
• If you suffer from kidney problems (renal insufficiency)
• If you have a liver condition
• If you suffer from neuronal disorders that affect your blood pressure, bowel or
sexual function (any neuropathy of the autonomic nervous system)
• If you have a hiatal hernia (herniation of an abdominal organ)
• If you ever experience decreased bowel movements or suffer from severe
constipation (decreased gastro-intestinal motility)
• If you have a heart condition such as:
• an abnormal heart tracing (ECG);
• a slow heart rate (bradycardia);
• relevant pre-existing cardiac diseases such as:
- cardiomyopathy (weak heart muscle)
- myocardial ischaemia (reduced blood flow to the heart)
- arrhythmia (irregular heartbeat)
- and heart failure
• If you have abnormally low levels of potassium (hypokalaemia), calcium
(hypocalcaemia) or magnesium (hypomagnesaemia) in your blood.
The active substance in Detrusitol 2 mg tablets is 2 mg of tolterodine tartrate,
equivalent to 1.37 mg of tolterodine.
Talk to your doctor or pharmacist before starting your treatment with Detrusitol if
you think any of these might apply to you.
Taking other medicines
Tolterodine, the active substance of Detrusitol, may interact with other medicinal
It is not recommended to use tolterodine in combination with:
• some antibiotics (containing e.g. erythromycin, clarithromycin)
• medicinal products used for the treatment of fungal infections (containing e.g.
• medicinal products used for the treatment of HIV.
Detrusitol should be used with caution when taken in combination with:
• medicines that affect the passage of food (containing e.g. metoclopramide and
• medicines for the treatment of irregular heartbeat (containing e.g. amiodarone,
sotalol, quinidine, procainamide)
• other medicines with a similar mode of action to Detrusitol (antimuscarinic
properties) or medicines with an opposite mode of action to Detrusitol (cholinergic
properties). Ask your doctor if you are unsure.
Please tell your doctor if you are taking or have recently taken any other medicines,
including medicines obtained without a prescription.
5. How to store DETRUSITOL
Keep Detrusitol out of the reach and sight of children.
Do not use Detrusitol after the expiry date which is stated on the label/carton. The
expiry date refers to the last day of that month.
6. Further information
What Detrusitol contains
The active substance in Detrusitol 1 mg tablets is 1 mg of tolterodine tartrate,
equivalent to 0.68 mg of tolterodine.
The other ingredients are:
Core: Microcrystalline cellulose, calcium hydrogen phosphate dihydrate, sodium
starch glycollate, magnesium stearate and colloidal anhydrous silica.
Film coating: Hypromellose, microcrystalline cellulose, stearic acid and titanium dioxide
What Detrusitol looks like and contents of the pack
Detrusitol 1 mg tablets are white, round, biconvex and marked with arcs above and
below the lettering TO.
Detrusitol 2 mg tablets are white, round, biconvex and marked with arcs above and
below the lettering DT.
Detrusitol 1 mg and 2 mg tablets are available in the following pack sizes:
Blister packs containing;
- 20 tablets (2 strips of 10)
- 30 tablets (3 strips of 10)
- 50 tablets (5 strips of 10)
- 100 tablets (10 strips of 10)
- 14 tablets (1 strip of 14)
- 28 tablets (2 strips of 14)
- 56 tablets (4 strips of 14)
- 280 tablets
- 560 tablets
Bottles containing 60 or 500 tablets.
Please note that not all the above pack sizes may be marketed.
Marketing authorisation holder and manufacturer
CT 13 9NJ
Pfizer Italia S.r.l
Località Marino del Tronto
63100 - Ascoli Piceno (AP)
This medicinal product is authorised in the following Member States of the EEA under
the trade name Detrusitol:
Austria, Belgium, Luxembourg, Finland, France, Germany, Greece, Ireland, Italy,
Netherlands, Portugal, Spain, Sweden, United Kingdom
This leaflet was last revised in 07/2015
Ref DT 13_0
Taking Detrusitol with food and drink
Detrusitol can be taken before, after or during a meal.
Pregnancy and breast-feeding
You should not use Detrusitol when you are pregnant. Tell your doctor immediately
if you are pregnant, think you are pregnant or are planning to become pregnant.
It is not known if tolterodine, the active substance of Detrusitol, is excreted in the
mother’s breast milk. Breast-feeding is not recommended during administration of
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Detrusitol may make you feel dizzy, tired or affect your sight; your ability to drive
or operate machinery may be affected.
3. How to take DETRUSITOL
Always take Detrusitol exactly as your doctor has told you. You should check with
your doctor or pharmacist if you are not sure.
The usual dose is one 2 mg tablet twice daily, except for patients who have a kidney
or a liver condition or troublesome side effects in which case your doctor may reduce
your dose to one 1 mg tablet twice daily.
Detrusitol is not recommended for children.
The tablets are for oral use and should be swallowed whole.
Duration of treatment
Your doctor will tell you how long your treatment with Detrusitol will last. Do not
stop treatment early because you do not see an immediate effect. Your bladder will
need some time to adapt. Finish the course of tablets prescribed by your doctor.
If you have not noticed any effect by then, talk to your doctor.
The benefit of the treatment should be re-evaluated after 2 or 3 months.
Always consult your doctor if you are thinking of stopping the treatment.
If you have taken more Detrusitol than you should:
If you or somebody else takes too many tablets, contact your doctor or pharmacist
If you forget to take Detrusitol
If you forget to take a dose at the usual time, take it as soon as you remember unless
it is almost time for your next dose. In that case, omit the forgotten dose and follow
the normal dose schedule.
Do not take a double dose to make up for a forgotten one.
If you have any further questions on the use of this product, ask your doctor or
4. Possible side effects
Like all medicines, Detrusitol can cause side effects, although not everybody gets
You should see your doctor immediately or go to the casualty department if you
experience symptoms of angioedema such as:
• swollen face, tongue or pharynx
• difficulty to swallow
• hives and difficulty in breathing
You should also seek medical attention if you experience a hypersensitivity reaction
(for example itching, rash, hives, difficulty breathing). This occurs uncommonly
(occurs in less than 1 in 100 patients).
Tell your doctor immediately or go to the casualty department if you notice any of
• chest pain, difficulty breathing or getting tired easily (even at rest), difficulty
breathing at night, swelling of the legs.
These may be symptoms of heart failure. This occurs uncommonly (occurs in less
than 1 in 100 patients).
The following side effects have been observed in Detrusitol with the following
Very common side effects (occurs in more than 1 in 10 patients) are:
• Dry mouth
Common side effects (occurs in less than 1 in 10 patients) are:
• Dizziness, sleepiness, sensation of pins and needles in the fingers and toes
• Dry eyes, blurred vision
• Difficulty with digestion (dyspepsia), constipation, abdominal pain, excessive
amounts of air or gases in the stomach or the intestine, vomiting
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.